Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT00502723
Other study ID # K060402
Secondary ID
Status Recruiting
Phase Phase 3
First received July 17, 2007
Last updated July 27, 2012
Start date December 2007
Est. completion date July 2012

Study information

Verified date January 2008
Source Assistance Publique - Hôpitaux de Paris
Contact Claude ABBOU, PU-PH
Phone 33 (0)1.49.81.25.51
Email claude.abbou@hmn.aphp.fr
Is FDA regulated No
Health authority France: Ministry of Health
Study type Interventional

Clinical Trial Summary

National multicentric prospective open study, comparing two current surgical methods: laparoscopic way versus open retropubic way among patients requiring a radical prostatectomy for a localised prostate cancer.


Description:

The aim of this study is to show that radical prostatectomy by laparoscopic way could obtain carcinological results not lower than theses with radical retropubic surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 1440
Est. completion date July 2012
Est. primary completion date July 2012
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Male, old patient of less than 70 years,

- having a prostate cancer proven histologically, requiring a radical prostatectomy.

- Clinical stage T1c and rate of PSA (with 20 ng/ml).

- Osseous scintiscanning and abdomen-pelvic scanner negative.

- Patient informed of the study and its participation.

- Patient affiliated to a social security system.

Exclusion Criteria:

- Contra-indication with the surgery or the anaesthesia.

- Antecedent of prostate resection or adenomectomy.

- Antecedent of inguinal hernia treatment.

- Antecedent of deep venous thrombosis of the lower limbs or pulmonary embolism

- Patient privatized of freedom.

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Radical retropubic prostatectomy
Radical retropubic prostatectomy
Radical laparoscopy prostatectomy
Radical laparoscopy prostatectomy

Locations

Country Name City State
France Groupe Hospitalier Albert Chenevier Henri Mondor Creteil

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary laparoscopic way versus open retropubic way among patients requiring a radical prostatectomy for a localised prostate cancer. during the study No
Secondary Carcinological (percentage of positive surgical margins, percentage of capsular crossing). after the surgical No
Secondary Functional (urinary continence, sexuality, quality of life) at 2 years No
Secondary per and post operational morbidity during the 36 months No
Secondary economic duration and cost of hospitalization No
See also
  Status Clinical Trial Phase
Completed NCT03653819 - High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs N/A
Withdrawn NCT05191017 - Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC Phase 1/Phase 2
Completed NCT00970203 - Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer Phase 2
Not yet recruiting NCT06363266 - A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers N/A
Active, not recruiting NCT02003924 - Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Phase 3
Completed NCT00643617 - CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry N/A
Completed NCT00844792 - Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer Phase 2
Completed NCT01303705 - Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer Phase 1
Completed NCT02578940 - Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer Phase 3
Completed NCT04057859 - PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training
Completed NCT00564928 - A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer Phase 2
Completed NCT02958787 - Vessel Sparing Prostate Radiation Therapy Phase 2
Completed NCT01897207 - Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer Phase 1/Phase 2
Recruiting NCT05241236 - MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
Active, not recruiting NCT03939689 - Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abiraterone Phase 2
Completed NCT02274350 - The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side Effects N/A
Completed NCT00744549 - Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance Phase 2
Recruiting NCT05252390 - NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors Phase 1/Phase 2
Completed NCT02212548 - Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal Dose N/A
Completed NCT04017325 - European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up